Cerebrovascular Response to Propofol, Fentanyl, and Midazolam in Moderate/Severe Traumatic Brain Injury: A Scoping Systematic Review of the Human and Animal Literature

Intravenous propofol, fentanyl, and midazolam are utilized commonly in critical care for metabolic suppression and anesthesia. The impact of propofol, fentanyl, and midazolam on cerebrovasculature and cerebral blood flow (CBF) is unclear in traumatic brain injury (TBI) and may carry important implic...

Full description

Bibliographic Details
Main Authors: Logan Froese, Joshua Dian, Carleen Batson, Alwyn Gomez, Bertram Unger, Frederick A. Zeiler
Format: Article
Language:English
Published: Mary Ann Liebert 2020-10-01
Series:Neurotrauma Reports
Subjects:
Online Access:https://www.liebertpub.com/doi/full/10.1089/NEUR.2020.0040
_version_ 1827374201225347072
author Logan Froese
Joshua Dian
Carleen Batson
Alwyn Gomez
Bertram Unger
Frederick A. Zeiler
author_facet Logan Froese
Joshua Dian
Carleen Batson
Alwyn Gomez
Bertram Unger
Frederick A. Zeiler
author_sort Logan Froese
collection DOAJ
description Intravenous propofol, fentanyl, and midazolam are utilized commonly in critical care for metabolic suppression and anesthesia. The impact of propofol, fentanyl, and midazolam on cerebrovasculature and cerebral blood flow (CBF) is unclear in traumatic brain injury (TBI) and may carry important implications, as care is shifting to focus on cerebrovascular reactivity monitoring/directed therapies. The aim of this study was to perform a scoping review of the literature on the cerebrovascular/CBF effects of propofol, fentanyl, and midazolam in human patients with moderate/severe TBI and animal models with TBI. A search of MEDLINE, BIOSIS, EMBASE, Global Health, SCOPUS, and the Cochrane Library from inception to May 2020 was performed. All articles were included pertaining to the administration of propofol, fentanyl, and midazolam, in which the impact on CBF/cerebral vasculature was recorded. We identified 14 studies: 8 that evaluated propofol, 5 that evaluated fentanyl, and 2 that evaluated midazolam. All studies suffered from significant limitations, including: small sample size, and heterogeneous design and measurement techniques. In general, there was no significant change seen in CBF/cerebrovascular response to administration of propofol, fentanyl, or midazolam during experiments where PCO2 and mean arterial pressure (MAP) were controlled. This review highlights the current knowledge gap surrounding the impact of commonly utilized sedative drugs in TBI care. This work supports the need for dedicated studies, both experimental and human-based, evaluating the impact of these drugs on CBF and cerebrovascular reactivity/response in TBI.
first_indexed 2024-03-08T11:29:28Z
format Article
id doaj.art-d6966c2c1b7c4561b2920b8f7c5d2980
institution Directory Open Access Journal
issn 2689-288X
language English
last_indexed 2024-03-08T11:29:28Z
publishDate 2020-10-01
publisher Mary Ann Liebert
record_format Article
series Neurotrauma Reports
spelling doaj.art-d6966c2c1b7c4561b2920b8f7c5d29802024-01-26T04:18:51ZengMary Ann LiebertNeurotrauma Reports2689-288X2020-10-011110011210.1089/NEUR.2020.0040Cerebrovascular Response to Propofol, Fentanyl, and Midazolam in Moderate/Severe Traumatic Brain Injury: A Scoping Systematic Review of the Human and Animal LiteratureLogan FroeseJoshua DianCarleen BatsonAlwyn GomezBertram UngerFrederick A. ZeilerIntravenous propofol, fentanyl, and midazolam are utilized commonly in critical care for metabolic suppression and anesthesia. The impact of propofol, fentanyl, and midazolam on cerebrovasculature and cerebral blood flow (CBF) is unclear in traumatic brain injury (TBI) and may carry important implications, as care is shifting to focus on cerebrovascular reactivity monitoring/directed therapies. The aim of this study was to perform a scoping review of the literature on the cerebrovascular/CBF effects of propofol, fentanyl, and midazolam in human patients with moderate/severe TBI and animal models with TBI. A search of MEDLINE, BIOSIS, EMBASE, Global Health, SCOPUS, and the Cochrane Library from inception to May 2020 was performed. All articles were included pertaining to the administration of propofol, fentanyl, and midazolam, in which the impact on CBF/cerebral vasculature was recorded. We identified 14 studies: 8 that evaluated propofol, 5 that evaluated fentanyl, and 2 that evaluated midazolam. All studies suffered from significant limitations, including: small sample size, and heterogeneous design and measurement techniques. In general, there was no significant change seen in CBF/cerebrovascular response to administration of propofol, fentanyl, or midazolam during experiments where PCO2 and mean arterial pressure (MAP) were controlled. This review highlights the current knowledge gap surrounding the impact of commonly utilized sedative drugs in TBI care. This work supports the need for dedicated studies, both experimental and human-based, evaluating the impact of these drugs on CBF and cerebrovascular reactivity/response in TBI.https://www.liebertpub.com/doi/full/10.1089/NEUR.2020.0040brain injurycerebral blood flowcerebrovascular responsefentanylmidazolampropofol
spellingShingle Logan Froese
Joshua Dian
Carleen Batson
Alwyn Gomez
Bertram Unger
Frederick A. Zeiler
Cerebrovascular Response to Propofol, Fentanyl, and Midazolam in Moderate/Severe Traumatic Brain Injury: A Scoping Systematic Review of the Human and Animal Literature
Neurotrauma Reports
brain injury
cerebral blood flow
cerebrovascular response
fentanyl
midazolam
propofol
title Cerebrovascular Response to Propofol, Fentanyl, and Midazolam in Moderate/Severe Traumatic Brain Injury: A Scoping Systematic Review of the Human and Animal Literature
title_full Cerebrovascular Response to Propofol, Fentanyl, and Midazolam in Moderate/Severe Traumatic Brain Injury: A Scoping Systematic Review of the Human and Animal Literature
title_fullStr Cerebrovascular Response to Propofol, Fentanyl, and Midazolam in Moderate/Severe Traumatic Brain Injury: A Scoping Systematic Review of the Human and Animal Literature
title_full_unstemmed Cerebrovascular Response to Propofol, Fentanyl, and Midazolam in Moderate/Severe Traumatic Brain Injury: A Scoping Systematic Review of the Human and Animal Literature
title_short Cerebrovascular Response to Propofol, Fentanyl, and Midazolam in Moderate/Severe Traumatic Brain Injury: A Scoping Systematic Review of the Human and Animal Literature
title_sort cerebrovascular response to propofol fentanyl and midazolam in moderate severe traumatic brain injury a scoping systematic review of the human and animal literature
topic brain injury
cerebral blood flow
cerebrovascular response
fentanyl
midazolam
propofol
url https://www.liebertpub.com/doi/full/10.1089/NEUR.2020.0040
work_keys_str_mv AT loganfroese cerebrovascularresponsetopropofolfentanylandmidazolaminmoderateseveretraumaticbraininjuryascopingsystematicreviewofthehumanandanimalliterature
AT joshuadian cerebrovascularresponsetopropofolfentanylandmidazolaminmoderateseveretraumaticbraininjuryascopingsystematicreviewofthehumanandanimalliterature
AT carleenbatson cerebrovascularresponsetopropofolfentanylandmidazolaminmoderateseveretraumaticbraininjuryascopingsystematicreviewofthehumanandanimalliterature
AT alwyngomez cerebrovascularresponsetopropofolfentanylandmidazolaminmoderateseveretraumaticbraininjuryascopingsystematicreviewofthehumanandanimalliterature
AT bertramunger cerebrovascularresponsetopropofolfentanylandmidazolaminmoderateseveretraumaticbraininjuryascopingsystematicreviewofthehumanandanimalliterature
AT frederickazeiler cerebrovascularresponsetopropofolfentanylandmidazolaminmoderateseveretraumaticbraininjuryascopingsystematicreviewofthehumanandanimalliterature